{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2025-11-07",
    "results": {
      "skip": 0,
      "limit": 10,
      "total": 28630
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20200914",
          "review_priority": "STANDARD",
          "submission_class_code": "UNKNOWN"
        }
      ],
      "application_number": "ANDA211211",
      "sponsor_name": "FRESENIUS KABI USA",
      "openfda": {
        "application_number": [
          "ANDA211211"
        ],
        "brand_name": [
          "DEXTROSE AND SODIUM CHLORIDE"
        ],
        "generic_name": [
          "DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE"
        ],
        "manufacturer_name": [
          "Fresenius Kabi USA, LLC",
          "BECTON DICKINSON AND COMPANY"
        ],
        "product_ndc": [
          "63323-870",
          "17271-735"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "DEXTROSE MONOHYDRATE",
          "SODIUM CHLORIDE"
        ],
        "rxcui": [
          "1795344",
          "1795346"
        ],
        "spl_id": [
          "449bf5b8-ff7c-4d79-a1d2-03886440257d",
          "69075560-be94-4804-ab7b-d8ebce41739a"
        ],
        "spl_set_id": [
          "68cc9c41-ed24-4f76-8efb-2936ae3ddd8d",
          "c1d0f42e-3494-4217-8f86-e9f34d930e82"
        ],
        "package_ndc": [
          "63323-870-01",
          "63323-870-10",
          "63323-870-04",
          "63323-870-74",
          "17271-735-06",
          "17271-735-07"
        ],
        "unii": [
          "LX22YL083G",
          "451W47IQ8X"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "DEXTROSE 5% AND SODIUM CHLORIDE 0.9%",
          "active_ingredients": [
            {
              "name": "DEXTROSE",
              "strength": "5GM/100ML"
            },
            {
              "name": "SODIUM CHLORIDE",
              "strength": "900MG/100ML"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Prescription",
          "te_code": "AP"
        }
      ]
    },
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "TA",
          "submission_status_date": "20190719",
          "review_priority": "STANDARD",
          "submission_class_code": "UNKNOWN",
          "application_docs": [
            {
              "id": "59598",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/211560Orig1s000TAltr.pdf",
              "date": "20190806",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "ANDA211560",
      "sponsor_name": "ALEMBIC PHARMS LTD"
    },
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20220315",
          "review_priority": "STANDARD",
          "submission_class_code": "UNKNOWN",
          "application_docs": [
            {
              "id": "71758",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/211884Orig1s000ltr.pdf",
              "date": "20220809",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "ANDA211884",
      "sponsor_name": "VISTAPHARM LLC",
      "openfda": {
        "application_number": [
          "ANDA211884"
        ],
        "brand_name": [
          "SUCRALFATE"
        ],
        "generic_name": [
          "SUCRALFATE ORAL SUSPENSION",
          "SUCRALFATE"
        ],
        "manufacturer_name": [
          "Major Pharmaceuticals",
          "PAI Holdings, LLC dba PAI Pharma",
          "VistaPharm, LLC"
        ],
        "product_ndc": [
          "0904-7470",
          "0121-0974",
          "66689-305"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "SUCRALFATE"
        ],
        "rxcui": [
          "313123"
        ],
        "spl_id": [
          "22759eaf-980b-4683-abbf-317e56323541",
          "76b5c0b5-ccbd-45d9-abdd-7521af17d1cb",
          "f133ac10-0969-47cb-932a-7b100b05105c"
        ],
        "spl_set_id": [
          "98a8fedd-fa06-416a-8a85-b899631978f9",
          "113a068a-2ce9-421c-8b89-87ce30e19225",
          "cbfbe146-5d42-4a55-9050-df2b5581487a"
        ],
        "package_ndc": [
          "0904-7470-66",
          "0904-7470-56",
          "0904-7470-01",
          "0904-7470-18",
          "0904-7470-95",
          "0904-7470-72",
          "0121-0974-10",
          "0121-0974-94",
          "0121-0974-40",
          "0121-0974-50",
          "0121-0974-00",
          "66689-305-16"
        ],
        "nui": [
          "N0000175801",
          "M0015420"
        ],
        "pharm_class_epc": [
          "Aluminum Complex [EPC]"
        ],
        "pharm_class_cs": [
          "Organometallic Compounds [CS]"
        ],
        "unii": [
          "XX73205DH5"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "SUCRALFATE",
          "active_ingredients": [
            {
              "name": "SUCRALFATE",
              "strength": "1GM/10ML"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "SUSPENSION",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    },
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20250415",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20250508",
          "review_priority": "UNKNOWN",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20221006",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20190103",
          "review_priority": "STANDARD",
          "submission_class_code": "UNKNOWN",
          "application_docs": [
            {
              "id": "56637",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/208031Orig1s000TALtr.pdf",
              "date": "20181206",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "ANDA208031",
      "sponsor_name": "LUPIN LTD",
      "openfda": {
        "application_number": [
          "ANDA208031"
        ],
        "brand_name": [
          "LURASIDONE HYDROCHLORIDE"
        ],
        "generic_name": [
          "LURASIDONE HYDROCHLORIDE"
        ],
        "manufacturer_name": [
          "Lupin Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "68180-670",
          "68180-671",
          "68180-672",
          "68180-673",
          "68180-674"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "LURASIDONE HYDROCHLORIDE"
        ],
        "rxcui": [
          "1040031",
          "1040041",
          "1235247",
          "1297278",
          "1431235"
        ],
        "spl_id": [
          "8d77b0dd-8cc2-44da-afed-1e5cb75bed99"
        ],
        "spl_set_id": [
          "74f2429b-71df-47f0-9cb5-98685372a9b8"
        ],
        "package_ndc": [
          "68180-670-06",
          "68180-671-06",
          "68180-672-06",
          "68180-673-06",
          "68180-674-06"
        ],
        "unii": [
          "O0P4I5851I"
        ]
      },
      "products": [
        {
          "product_number": "005",
          "reference_drug": "No",
          "brand_name": "LURASIDONE HYDROCHLORIDE",
          "active_ingredients": [
            {
              "name": "LURASIDONE HYDROCHLORIDE",
              "strength": "120MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        },
        {
          "product_number": "003",
          "reference_drug": "No",
          "brand_name": "LURASIDONE HYDROCHLORIDE",
          "active_ingredients": [
            {
              "name": "LURASIDONE HYDROCHLORIDE",
              "strength": "60MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        },
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "LURASIDONE HYDROCHLORIDE",
          "active_ingredients": [
            {
              "name": "LURASIDONE HYDROCHLORIDE",
              "strength": "20MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        },
        {
          "product_number": "004",
          "reference_drug": "No",
          "brand_name": "LURASIDONE HYDROCHLORIDE",
          "active_ingredients": [
            {
              "name": "LURASIDONE HYDROCHLORIDE",
              "strength": "80MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        },
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "LURASIDONE HYDROCHLORIDE",
          "active_ingredients": [
            {
              "name": "LURASIDONE HYDROCHLORIDE",
              "strength": "40MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    },
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20251103",
          "review_priority": "STANDARD",
          "submission_class_code": "UNKNOWN",
          "application_docs": [
            {
              "id": "48977",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208415TA_ltr.pdf",
              "date": "20170713",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "ANDA208415",
      "sponsor_name": "AUROBINDO PHARMA LTD",
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "LINAGLIPTIN",
          "active_ingredients": [
            {
              "name": "LINAGLIPTIN",
              "strength": "5MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    },
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20220110",
          "review_priority": "STANDARD",
          "submission_class_code": "UNKNOWN"
        }
      ],
      "application_number": "ANDA208769",
      "sponsor_name": "ACTAVIS LABS UT INC",
      "openfda": {
        "application_number": [
          "ANDA208769"
        ],
        "brand_name": [
          "SCOPOLAMINE"
        ],
        "generic_name": [
          "SCOPOLAMINE"
        ],
        "manufacturer_name": [
          "Actavis Pharma, Inc."
        ],
        "product_ndc": [
          "0591-2258"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "TRANSDERMAL"
        ],
        "substance_name": [
          "SCOPOLAMINE"
        ],
        "rxcui": [
          "226552"
        ],
        "spl_id": [
          "59f10193-3604-4f3c-a9f7-68a55004f3d0"
        ],
        "spl_set_id": [
          "800b6421-48eb-47f5-b255-c12f75e59068"
        ],
        "package_ndc": [
          "0591-2258-04",
          "0591-2258-79",
          "0591-2258-23"
        ],
        "nui": [
          "N0000175574",
          "N0000175370"
        ],
        "pharm_class_epc": [
          "Anticholinergic [EPC]"
        ],
        "pharm_class_moa": [
          "Cholinergic Antagonists [MoA]"
        ],
        "unii": [
          "DL48G20X8X"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "SCOPOLAMINE",
          "active_ingredients": [
            {
              "name": "SCOPOLAMINE",
              "strength": "1MG/72HR"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "SYSTEM",
          "route": "TRANSDERMAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    },
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20220228",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20181121",
          "review_priority": "STANDARD",
          "submission_class_code": "UNKNOWN"
        }
      ],
      "application_number": "ANDA209484",
      "sponsor_name": "HIKMA",
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "DICLOFENAC SODIUM",
          "active_ingredients": [
            {
              "name": "DICLOFENAC SODIUM",
              "strength": "1%"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "GEL",
          "route": "TOPICAL",
          "marketing_status": "Discontinued"
        }
      ]
    },
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "10",
          "submission_status": "AP",
          "submission_status_date": "20221027",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20201002",
          "submission_class_code": "REMS",
          "submission_class_code_description": "REMS"
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20180423",
          "review_priority": "STANDARD",
          "submission_class_code": "UNKNOWN",
          "application_docs": [
            {
              "id": "76250",
              "url": "https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=364",
              "date": "20231103",
              "type": "REMS"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20190912",
          "submission_class_code": "REMS",
          "submission_class_code_description": "REMS"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "13",
          "submission_status": "AP",
          "submission_status_date": "20240912",
          "submission_class_code": "REMS",
          "submission_class_code_description": "REMS"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20200803",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "11",
          "submission_status": "AP",
          "submission_status_date": "20221012",
          "submission_class_code": "REMS",
          "submission_class_code_description": "REMS"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20200417",
          "submission_class_code": "REMS",
          "submission_class_code_description": "REMS"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20200803",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20190530",
          "submission_class_code": "REMS",
          "submission_class_code_description": "REMS"
        }
      ],
      "application_number": "ANDA209824",
      "sponsor_name": "TEVA PHARMS USA",
      "openfda": {
        "application_number": [
          "ANDA209824"
        ],
        "brand_name": [
          "VIGABATRIN"
        ],
        "generic_name": [
          "VIGABATRIN"
        ],
        "manufacturer_name": [
          "Actavis Pharma, Inc."
        ],
        "product_ndc": [
          "0591-3955"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "VIGABATRIN"
        ],
        "rxcui": [
          "250820"
        ],
        "spl_id": [
          "c388a7b2-5b58-40c3-9949-2cdcf8b57f87"
        ],
        "spl_set_id": [
          "1ce1c52d-441a-4ed7-afff-568192197454"
        ],
        "package_ndc": [
          "0591-3955-11",
          "0591-3955-50"
        ],
        "nui": [
          "N0000175753"
        ],
        "pharm_class_epc": [
          "Anti-epileptic Agent [EPC]"
        ],
        "unii": [
          "GR120KRT6K"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "VIGABATRIN",
          "active_ingredients": [
            {
              "name": "VIGABATRIN",
              "strength": "500MG/PACKET"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "FOR SOLUTION",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AA"
        }
      ]
    },
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20180423",
          "review_priority": "STANDARD",
          "submission_class_code": "UNKNOWN"
        }
      ],
      "application_number": "ANDA209118",
      "sponsor_name": "CHARTWELL RX",
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "FLUOCINONIDE",
          "active_ingredients": [
            {
              "name": "FLUOCINONIDE",
              "strength": "0.05%"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "SOLUTION",
          "route": "TOPICAL",
          "marketing_status": "Prescription",
          "te_code": "AT"
        }
      ]
    },
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "TA",
          "submission_status_date": "20181212",
          "review_priority": "STANDARD",
          "submission_class_code": "UNKNOWN",
          "application_docs": [
            {
              "id": "57278",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/210159Orig1s000TAltr.pdf",
              "date": "20190118",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "ANDA210159",
      "sponsor_name": "TORRENT PHARMA INC"
    }
  ]
}